Detail (Long)
In adults w/ DM and cost-related barriers, consider use of lower-cost medications for glycemic mgmt (i.e., metformin, SUs, TZDs, and human insulin) w/in the context of their risks for hypoglycemia, wt gain, CV and kidney events, and other adverse effects. [E]